SwastiChemEx: ReproCELL acquires 3D cell culture

Thursday 7 August 2014

ReproCELL acquires 3D cell culture


Reinnervate Ltd, one of the leading companies in the field of 3D cell culture, has been acquired by ReproCELL of Shin-Yokohama in Japan. ReproCELL, a pioneer in the field of induced pluripotent stem cell biology supplies iPSC-dervided Hepatocytes, Neurons and Cardiomyocytes as well as a range of media and reagents for stem cell culture.



ReproCELL intends to combine it’s iPSC-derived cells with the Alvetex range of 3D cell culture products to produce and sell next-generation tools for drug toxicity testing, neuroscience and cancer research.




ReproCELL also announced the acquisition of BioServe Inc of Maryland, USA, a leading supplier of human tissues and other biological samples with one of the largest commercial biorepositories in the world.

ReproCELL plans to use the unparalleled access to human tissues to generate a wide range of disease-related iPSC lines for production of human disease cell models.

No comments:

Post a Comment